Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Viatris Inc. | 1 | 0 | 0 | 0 | €9.72 | - | - |
| Merck KGaA | 3 | 1 | 0 | 0 | €167.60 | €146.00 | -12.888% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Bayer AG | 15 | 1 | 1 | 0 | €27.27 | €50.00 | 83.385% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €68.05 | €65.00 | -4.482% |
| Sanofi S.A. | 5 | 0 | 1 | 0 | €89.86 | €99.50 | 10.728% |
| GSK plc | 1 | 0 | 0 | 0 | €20.90 | - | - |
| Pfizer Inc. | 27 | 4 | 1 | 0 | €26.62 | €40.66 | 52.769% |
| Johnson & Johnson | 33 | 1 | 3 | 0 | €138.34 | €195.83 | 41.559% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €122.00 | €124.93 | 2.401% |
| AstraZeneca plc | 2 | 0 | 1 | 0 | €144.70 | €165.00 | 14.029% |
| Amgen Inc. | 25 | 0 | 4 | 0 | €280.10 | €297.31 | 6.145% |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 4 | 0 | €902.40 | €958.32 | 6.197% |
| Vertex Pharmaceuticals Inc. | 46 | 2 | 6 | 0 | €417.60 | €423.03 | 1.301% |
| Gilead Sciences Inc | 11 | 1 | 3 | 0 | €61.42 | €84.81 | 38.085% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €170.00 | -8.108% |
| Abbott Laboratories | 17 | 0 | 1 | 0 | €96.24 | €116.71 | 21.273% |
| Eli Lilly Corp. | 51 | 0 | 6 | 0 | €748.50 | €781.33 | 4.386% |